Based on the recent findings that NLRP3-associated inflammasome is upregulated in T2DM patients [44] and instigates obesity-induced inflammation in insulin resistance [45, 46], we have started to evaluate whether plasma mtDNA is oxidatively damaged in T2DM patients. The gene discussed is NLRP3; the disease is Insulin resistance.